House of Lords Business
Show full summary

Lord Dubs to ask Her Majesty's Government what assessment they have made of (1) advances in treatments for multiple sclerosis for NHS patients, including the recently approved first short course oral treatment, cladribine tablets; and (2) the extent to which new treatments will help to reduce burdens on NHS services.  HL2994

Question HL2994: tabled on 7 November 2017 and due for answer by 21 November 2017

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Dubs to ask Her Majesty's Government what assessment they have made of (1) advances in treatments for multiple sclerosis for NHS patients, including the recently approved first short course oral treatment, cladribine tablets; and (2) the extent to which new treatments will help to reduce burdens on NHS services.  HL2994
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Dubs
Labour
Life peer